← Product Code [LHI](/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/LHI) · K041222 # PINNACLE TPN MANAGEMENT SYSTEM TRANSFER SET (K041222) _B.Braun Medical, Inc. · LHI · Oct 14, 2004 · General Hospital · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/LHI/K041222 ## Device Facts - **Applicant:** B.Braun Medical, Inc. - **Product Code:** [LHI](/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/LHI.md) - **Decision Date:** Oct 14, 2004 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 880.5440 - **Device Class:** Class 2 - **Review Panel:** General Hospital ## Indications for Use The Pinnacle™ TPN Management System Transfer Set is to be used with the Pinnacle TPN Management System, a gravimetric pharmacy compounding device. The Pinnacle™ TPN Management System Transfer Set is intended to be used with the Pinnacle TPN Management System gravimetric pharmacy compounding device in the pharmacy to provide a sterile fluid path for the compounding of ingredients from multiple source containers into a final container. ## Device Story Pinnacle™ TPN Management System Transfer Set; sterile fluid path component for pharmacy compounding. Used with Pinnacle TPN Management System (gravimetric compounding device). Available in 6-lead or 9-lead configurations; includes vented or non-vented spikes; optional detachable lipid line for dual-chambered containers. Operated by pharmacy personnel to transfer ingredients from multiple source containers into a final container. Facilitates automated gravimetric compounding process; ensures sterile fluid delivery. Benefits patient by enabling accurate, sterile preparation of Total Parenteral Nutrition (TPN) formulations. ## Clinical Evidence No clinical data. Bench testing only. ## Technological Characteristics Fluid transfer set; 6-lead or 9-lead configuration; vented or non-vented spikes; detachable lipid line. Sterile fluid path. Mechanical device; no energy source or software. ## Regulatory Identification An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container. ## Special Controls *Classification.* Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9. ## Predicate Devices - Exacta-Mix™ 2400 Compounding System Administration Set ([K002705](/device/K002705.md)) - Automix® 3+3/AS Compounder Transfer Set ([K961008](/device/K961008.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ Pinnacle™ TPN Management System Transfer Set K041222 1 of 2 ## OCT 1 4 2004 # 7.0 510(k) Summary This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 5 807.92." | SUBMITTER: | B. Braun Medical Inc.
1601 Wallace Drive, Ste 150
Carrollton, TX 75006-6690
(972) 245.2243

Contact: Linda Morgan, RN, Senior Regulatory
Affairs Specialist | |---------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | DEVICE NAME: | Pinnacle™ TPN Management System Transfer Set | | COMMON OR USUAL
NAME: | I.V. Fluid Transfer Set | | DEVICE
CLASSIFICATION: | Class II per Code of Federal Regulations,
Title 21, § 880.5440, Intravascular Administration
Sets, product code LHI and NEP | | PREDICATE DEVICES: | Baxa Corporation
Exacta-Mix™ 2400 Compounding System
Administration Set,
K002705
Baxter Healthcare Corporation
Automix® 3+3/AS Compounder Transfer
Set,
K961008 | | DESCRIPTION: | The Pinnacle™ TPN Management System Transfer
Set is available in a 6-lead or a 9- lead configuration
with vented or non-vented spikes. The detachable
lipid line may be used when compounding lipid
formulations into a dual-chambered final container. | {1}------------------------------------------------ Pinnacle™ TPN Management System Transfer Set ### INTENDED USE: The Pinnacle™ TPN Management System Transfer Set is to be used with the Pinnacle TPN Management System, a gravimetric pharmacy compounding device. The Pinnacle™ TPN Management System Transfer Set is intended to be used with the Pinnacle TPN Management System gravimetric pharmacy compounding device in the pharmacy to provide a sterile fluid path for the compounding of ingredients from multiple source containers into a final container. ### SUBSTANTIAL EQUIVALENCE: The Pinnacle™ TPN Management System Transfer Set is similar in intended use, operation and function to Exacta-Mix 2400 Compounding System Administration Set, distributed by Baxa Corporation, K002705, and the Automix 3+3/AS Compounder Transfer Set, distributed by Baxter Healthcare corporation, K961008. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized depiction of an eagle, represented by three curved lines that suggest the bird's head, body, and tail feathers. Public Health Service OCT 1 4 2004 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Ms. Linda Morgan, RN Sr. Regulatory Affairs Specialist B. Braun Medical. Incorporated 1601 Wallace Drive, Suite 150 Carrollton, Texas 75006-6690 Re: K041222 Trade/Device Name: Pinnacle™ TPN Management System Transfer Set Regulation Number: 21 CFR 880.5440 Regulation Name: Intravascular Administration Set Regulatory Class: II Product Code: LHI Dated: August 26, 2004 Received: August 27, 2004 Dear Ms. Morgan: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ Page 2 - Ms. Morgan Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, Susan Rumm Chiu Lin, Ph.D. Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ Pinnacle™ TPN Management System Transfer Set #### Indications for Use Statement 2.0 Page _________________________________________________________________________________________________________________________________________________________________________ 1641222 । दर्द 510(k) Number (if known): _K041222 Pinnacle™ TPN Management System Transfer Set Device Name: Indications For Use: The Pinnacle Transfer Set is intended to be used with the Pinnacle TPN Management System gravimetric pharmacy compounding device in the pharmacy to provide a sterile fluid path for the compounding of ingredients from multiple source containers into a final container. Prescription Use X (Per 21 CFR 801.109) Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________ (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) OR Concurrence of CDRH, Office of Device Evaluation (ODE) Antony 29me (Division Sign-Off) Division of Anesthesiology, General Hospital, Infection Control. Dental Devices 510(k) Number ________________________________________________________________________________________________________________________________________________________________ --- **Source:** [https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/LHI/K041222](https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/LHI/K041222) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com